These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38538338)

  • 1. Genetic and Functional Analyses of Patients with Marked Hypo-High-Density Lipoprotein Cholesterolemia.
    Furuta Y; Osaki Y; Nakagawa Y; Han SI; Araki M; Shikama A; Ohuchi N; Yamazaki D; Matsuda E; Nohara S; Mizunoe Y; Kainoh K; Suehara Y; Ohno H; Takeuchi Y; Miyamoto T; Murayama Y; Sugano Y; Iwasaki H; Hirano KI; Koseki M; Nakano S; Tokiwa H; Sekiya M; Yahagi N; Matsuzaka T; Nakamagoe K; Tomidokoro Y; Mitsui J; Tsuji S; Suzuki H; Shimano H
    J Atheroscler Thromb; 2024 Sep; 31(9):1304-1318. PubMed ID: 38538338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
    Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
    Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
    Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
    Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.
    Tada H; Kawashiri MA; Nohara A; Saito R; Tanaka Y; Nomura A; Konno T; Sakata K; Fujino N; Takamura T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2015 Jun; 240(2):324-9. PubMed ID: 25875382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1.
    Guan JZ; Tamasawa N; Brunham LR; Matsui J; Murakami H; Suda T; Ochiai S; Tsutsui M; Kudou K; Satoh K; Hayden MR
    Am J Med Genet A; 2004 Nov; 130A(4):398-401. PubMed ID: 15384103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
    Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
    Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease.
    Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I
    Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
    Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
    J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1.
    El Khoury P; Couvert P; Elbitar S; Ghaleb Y; Abou-Khalil Y; Azar Y; Ayoub C; Superville A; Guérin M; Rabès JP; Varret M; Boileau C; Jambart S; Giral P; Carrié A; Le Goff W; Abifadel M
    J Clin Lipidol; 2018; 12(6):1374-1382. PubMed ID: 30361172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia.
    Carcora Y; Brook RD; Farhat L; Willer CJ; Rubenfire M; Kim DS
    J Clin Lipidol; 2018; 12(4):878-882. PubMed ID: 29773422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangier disease: epidemiology, pathophysiology, and management.
    Puntoni M; Sbrana F; Bigazzi F; Sampietro T
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.
    Fasano T; Zanoni P; Rabacchi C; Pisciotta L; Favari E; Adorni MP; Deegan PB; Park A; Hlaing T; Feher MD; Jones B; Uzak AS; Kardas F; Dardis A; Sechi A; Bembi B; Minuz P; Bertolini S; Bernini F; Calandra S
    Mol Genet Metab; 2012 Nov; 107(3):534-41. PubMed ID: 22959828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Electrodiagnostic, and Genetic Features of Tangier Disease in an Adolescent Girl with Presentation of Peripheral Neuropathy.
    Per H; Canpolat M; Bayram AK; Ulgen E; Baran B; Kardas F; Gumus H; Kumandas S; Bilguvar K; Çağlayan AO
    Neuropediatrics; 2015 Dec; 46(6):420-3. PubMed ID: 26479764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
    Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
    Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.
    Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK
    J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
    Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.
    Quazi F; Molday RS
    J Biol Chem; 2013 Nov; 288(48):34414-26. PubMed ID: 24097981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism.
    Ogura M
    J Pharmacol Sci; 2022 Oct; 150(2):81-89. PubMed ID: 36055755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.